COMPLERA

Emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate · Gilead Sciences, Inc.

Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for COMPLERA, covering 2011-08-10 to 2019-11-27. Get the full timeline:

Most recent: FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)